Literature DB >> 8225735

Radon exposure and leukaemia in adulthood.

J F Viel1.   

Abstract

Positive associations between leukaemia and radon concentrations have been observed in England, Scotland and Wales, and Canada. Results of a similar study for the populations of 41 French administrative areas ('départements') are reported for 1984-1986. The average indoor radon and gamma ray concentrations per 'département' range from 12 to 147 Bq.m-3 and from 28 to 142 nG.h-1, respectively. Acute lymphoid leukaemia mortality rate is similar to the national level, whereas an excess of acute myeloid leukaemia deaths is observed. According to Poisson regression models and modified tests for partial correlation, acute myeloid leukaemia mortality is significantly and positively related to indoor radon concentration whether or not adjustment is made for indoor gamma ray dose, socioeconomic status and linear gradient. This result reinforces the evidence that indoor exposure to high levels of radon is a leukaemic environmental hazard.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225735     DOI: 10.1093/ije/22.4.627

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  3 in total

1.  Association between indicators of cattle density and incidence of paediatric haemolytic-uraemic syndrome (HUS) in children under 15 years of age in France between 1996 and 2001: an ecological study.

Authors:  R Haus-Cheymol; E Espie; D Che; V Vaillant; H DE Valk; J C Desenclos
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

2.  Adult myeloid leukaemia, geology, and domestic exposure to radon and gamma radiation: a case control study in central Italy.

Authors:  F Forastiere; A Sperati; G Cherubini; M Miceli; A Biggeri; O Axelson
Journal:  Occup Environ Med       Date:  1998-02       Impact factor: 4.402

3.  Indoor residential radon exposure and risk of childhood acute myeloid leukaemia.

Authors:  M Steinbuch; C R Weinberg; J D Buckley; L L Robison; D P Sandler
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.